| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/19/2009 | EP2089015A2 Methods for treating disruptive behavior disorders |
| 08/19/2009 | EP2089011A1 Treatment of pervasive developmental disorders |
| 08/19/2009 | EP2088861A2 Benzimidazole compounds |
| 08/19/2009 | EP2035394B1 2-pyrazinecarboxamide derivatives |
| 08/19/2009 | EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases |
| 08/19/2009 | EP1937679B1 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 08/19/2009 | EP1915144A4 Method to reduce oxidative damage and improve mitochondrial efficiency |
| 08/19/2009 | EP1853232B1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them |
| 08/19/2009 | EP1838304B1 Heterocyclic aspartyl protease inhibitors |
| 08/19/2009 | EP1740585B1 Enantiomer-pure hexahydropyrrolocyclopentapyridine derivatives |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1414466B1 Combinations for the treatment of inflammatory disorders |
| 08/19/2009 | EP1343509B1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1183240B1 Beta2-adrenoceptor agonists |
| 08/19/2009 | EP1131424B1 Mutation of the parkin gene, compositions, methods and uses |
| 08/19/2009 | CN101511835A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
| 08/19/2009 | CN101511833A 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists |
| 08/19/2009 | CN101511832A Fused heterocyclic inhibitors of D-amino acid oxidase |
| 08/19/2009 | CN101511828A Heteroaryl derivatives as protein kinase inhibitors |
| 08/19/2009 | CN101511825A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3) |
| 08/19/2009 | CN101511824A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3) |
| 08/19/2009 | CN101511819A N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 08/19/2009 | CN101511807A Substituted benzamide modulators of the histamine H3 receptor |
| 08/19/2009 | CN101511805A Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands |
| 08/19/2009 | CN101511804A Cyclic sulfones useful as mitochondrial sodium-calcium exchangers |
| 08/19/2009 | CN101511802A Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 08/19/2009 | CN101511790A Substituted aminomethyl benzamide compounds |
| 08/19/2009 | CN101511787A Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use |
| 08/19/2009 | CN101511388A Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 08/19/2009 | CN101511383A Use of WNT5A for inhibiting scarring |
| 08/19/2009 | CN101511378A Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
| 08/19/2009 | CN101508693A Xylogen like flavonoid compounds, method of preparing the same and pharmaceutical use |
| 08/19/2009 | CN101508689A Synthesis of oroxylin |
| 08/19/2009 | CN101507856A Medicine cap capable of treating encephalatrophy and manufacture method thereof |
| 08/19/2009 | CN101507782A Mixed essential oil capable of treating brain atrophy and preparation method thereof |
| 08/19/2009 | CN101507755A Preparation method of high-purity magnolia bark total-phenol |
| 08/19/2009 | CN101507752A Prunella vulgaris extract dispersible tablets and preparation method and use thereof |
| 08/19/2009 | CN101507751A Use of Prunella vulgaris extract in preparing medicine for treating insomnia |
| 08/19/2009 | CN101507739A Biological agent containing human ARMET protein or oligonucleotide active constituent and use thereof |
| 08/19/2009 | CN101507736A Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100528888C Novel anticonvulsant derivative salts |
| 08/19/2009 | CN100528884C Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 08/19/2009 | CN100528876C Pyrrazolo-pyrimidine derivatives |
| 08/19/2009 | CN100528875C Crystal-free type Idi prone and its preparing method |
| 08/19/2009 | CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use |
| 08/19/2009 | CN100528872C Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 08/19/2009 | CN100528871C Benzothiazole derivatives as adenosine receptor ligands |
| 08/19/2009 | CN100528869C Silybin flavonolignan and their production method and use |
| 08/19/2009 | CN100528863C Method for manufacture of sertindole |
| 08/19/2009 | CN100528849C Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and high pure crystals of zonisamide |
| 08/19/2009 | CN100528844C Huperzine A derivative, preparation method and application thereof |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528255C Dose dispensing system and apparatus |
| 08/19/2009 | CN100528222C Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 08/19/2009 | CN100528214C Capsule for treating epilepsia and its preparing method |
| 08/19/2009 | CN100528184C Chinese medicine for treating headache |
| 08/19/2009 | CN100528182C Long acting, pain stopping liquor and its preparation process |
| 08/19/2009 | CN100528180C Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method |
| 08/19/2009 | CN100528175C Deporteinnized calf serum injection and its preparing method |
| 08/19/2009 | CN100528174C Combination of cytidine disodium triphosphate and arginine, and preparation method thereof |
| 08/19/2009 | CN100528164C Statin therapy for enhancing cognitive maintenance |
| 08/19/2009 | CN100528162C Pharmaceutical compositions |
| 08/19/2009 | CN100528156C Prevention of addiction in pain management |
| 08/19/2009 | CN100528152C 5-hydroxymethyl -2-furol and its derivative analogue medical use |
| 08/19/2009 | CN100528151C Pharmaceutical formulations of modafinil |
| 08/19/2009 | CN100528149C A composition for treating neurocerebrovascular disorders |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/18/2009 | US7576100 Muscarinic agonists |
| 08/18/2009 | US7576095 2-(p-Alkoxy- or p-fluoroalkylsulonyloxyphenyl)-1-phenyl-5-cyclohexyl- or 5-(1-piperdinyl)-4,5-dihydropyrrolo[3,2-c]pyridin-4-ones; treatment of obesity, psychiatric and neurological disorders |
| 08/18/2009 | US7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 08/18/2009 | US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 08/18/2009 | US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction |
| 08/18/2009 | US7576080 N-[3-(3-{[5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy}propoxy)phenyl]cyclopropanecarboxamide; PDE10 inhibitor; psychological, nervous system disorders; schizophrenia; cognition activators; drug abuse; antiepileptic agents; lupus; antitumor, -carcinogenic agents; hyperglycemica agents; sarcoidosis |
| 08/18/2009 | US7576078 Tetrahydroquinoline analogues as muscarinic agonists |
| 08/18/2009 | US7576077 9-{[5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-3-pyridin-4-yl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine; Group 1 receptor subtype; analgesics; psychological disorders; gastroesophageal reflux; neuroprotectans; antiischemic agents; hyperglycemic agents; neurodegenerative disease |
| 08/18/2009 | US7576050 Glucagon-like peptides and ependins for use in treatment and prevention of diabetes and neurodegenerative conditions; neuroprotective agents; neurotrophic factors |
| 08/18/2009 | US7575894 Human recombinant beta-interferon with improved solubility |
| 08/18/2009 | US7575857 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy |
| 08/18/2009 | US7575742 Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist |
| 08/18/2009 | CA2585557C Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2440710C Medicine of post-traumatic stress disorder |
| 08/18/2009 | CA2413736C Thorium or actinium radionuclides for endoradionuclide therapy |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2409379C Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
| 08/18/2009 | CA2404616C Use of vegf and homologues to treat neuron disorders |
| 08/18/2009 | CA2393568C Diarylmethylpiperazines |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2387394C Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
| 08/18/2009 | CA2377254C Non-malignant disease treatment with ras antagonists |
| 08/18/2009 | CA2276764C Acridine derivatives as opioid analgesics |